News
1d
Fintel on MSNBTIG Upgrades Ally Financial (ALLY)Fintel reports that on July 14, 2025, BTIG upgraded their outlook for Ally Financial (NYSE:ALLY) from Sell to Neutral.
1d
Fintel on MSNBTIG Downgrades TechnipFMC (FTI)Fintel reports that on July 14, 2025, BTIG downgraded their outlook for TechnipFMC (NYSE:FTI) from Buy to Neutral. Analyst ...
I-Mab (NASDAQ: IMAB) (the “Company”), a U.S.-based, global biotech company, focused on the development of precision ...
BTIG downgraded AFRM to "neutral" from "buy" Though shares of buy-now-pay-later name Affirm Holdings Inc (NASDAQ:AFRM) have ...
BTIG downgraded shares of Affirm and PROG Holdings ahead of second-quarter earnings, flagging concerns over weakening credit trends and increased competition from traditional lenders. Brokerage ...
As of Monday, the S&P 500 has been trading above its 20-day moving average for 55 days. That's the longest stretch since ...
Detailed price information for Intuitive Surg Inc (ISRG-Q) from The Globe and Mail including charting and trades.
Billionaire Kerr Neilson has bought over $8 million worth of shares in Flutter Entertainment plc (NYSE:FLUT), representing ...
BTIG to provide strategic advice on capital markets positioning, institutional engagement, and investor outreachAppointment ...
BTIG made the claim in a lawsuit filed late Monday in California state court and seeks at least $200 million in damages. Have a confidential tip for our reporters? Get in Touch.
BTIG has decided to maintain its Buy rating of Viking Therapeutics (NASDAQ:VKTX) and raise its price target from $20.00 to $31.00. Shares of Viking Therapeutics are trading up 4.15% over the last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results